257 related articles for article (PubMed ID: 29035843)
21. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
23. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
[TBL] [Abstract][Full Text] [Related]
24. Induced pluripotent stem cells from goat fibroblasts.
Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
[TBL] [Abstract][Full Text] [Related]
25. Efficient induction of pluripotent stem cells from menstrual blood.
Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
[TBL] [Abstract][Full Text] [Related]
27. Generation of three iPSC cell lines (SIAISi006-A, SIAISi007-A and SIAISi008-A) from a 66-year-old Alzheimer's disease (AD) patient and her two unaffected children from Chinese Han population.
Zhang W; Dai Q; Hua Y; Di W; Guo J; Zhao J; Deng Y; Wang Y
Stem Cell Res; 2021 Mar; 51():102172. PubMed ID: 33472125
[TBL] [Abstract][Full Text] [Related]
28. Episomal Reprogramming of Human Peripheral Blood Mononuclear Cells into Pluripotency.
Wen W; Cheng T; Zhang XB
Methods Mol Biol; 2021; 2239():117-133. PubMed ID: 33226616
[TBL] [Abstract][Full Text] [Related]
29. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
[TBL] [Abstract][Full Text] [Related]
30. Generation of human iPSC line GRX-MCiPS4F-A2 from adult peripheral blood mononuclear cells (PBMCs) with Spanish genetic background.
Cabrera S; Ji AR; Frejo L; Ramos-Mejia V; Romero T; Real P; Lopez-Escamez JA
Stem Cell Res; 2015 Sep; 15(2):337-40. PubMed ID: 26284980
[TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
[TBL] [Abstract][Full Text] [Related]
32. Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation.
Huynh LM; Shinagawa T; Ishii S
Stem Cells Dev; 2016 Feb; 25(3):251-8. PubMed ID: 26649967
[TBL] [Abstract][Full Text] [Related]
33. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
34. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
35. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
[TBL] [Abstract][Full Text] [Related]
36. Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation.
Wang Y; Zhang J; Hu J; Li G; Lei Y; Zhao J
Stem Cell Res; 2019 Apr; 36():101391. PubMed ID: 30831521
[TBL] [Abstract][Full Text] [Related]
37. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
[TBL] [Abstract][Full Text] [Related]
38. Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.
Sivapatham R; Zeng X
Methods Mol Biol; 2016; 1353():25-44. PubMed ID: 25520284
[TBL] [Abstract][Full Text] [Related]
39. Establishment of TUSMi003-A, an induced pluripotent stem cell (iPSC) line from a 62-year old Chinese Han patient with Alzheimer's disease with ApoE3/4 genetic background.
Wang Y; Yu H; Zhang Y; Zhang J; Chen K; Sun H; Meng S; Li G; Lei Y; Zhao J
Stem Cell Res; 2018 Mar; 27():57-60. PubMed ID: 29328972
[TBL] [Abstract][Full Text] [Related]
40. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
